Moderna (MRNA) PT Raised to $30 at Morgan Stanley
Tweet
Share
E-mailGet Alerts MRNA Hot Sheet
Price: $63.65 --0%
Rating Summary:
5 Buy, 21 Hold, 4 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 11 | Down: 14 | New: 9
Rating Summary:
5 Buy, 21 Hold, 4 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 11 | Down: 14 | New: 9
Join SI Premium – FREE
Morgan Stanley analyst Matthew Harrison raised the price target on Moderna (NASDAQ: MRNA) to $30.00 (from $29.00) while maintaining a Overweight rating.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- TerraVest Industries Inc (TVK:CN) PT Raised to Cdn$170 at BMO Capital
- American Healthcare REIT, Inc (AHR) PT Raised to $61 at RBC Capital
- AutoCanada (ACQ:CN) (AOCIF) PT Raised to Cdn$27 at BMO Capital
Create E-mail Alert Related Categories
Analyst PT ChangeRelated Entities
Morgan StanleySign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
